Assenagon Asset Management’s ADMA Biologics ADMA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-12,050	Closed	-$219K	–	1163
2025 Q2	$219K	Sell	12,050 -387,872	-97%	-$7.91M	﹤0.01%	1116
2025 Q1	$7.93M	Sell	399,922 -191,757	-32%	-$3.32M	0.01%	463
2024 Q4	$10.1M	Sell	591,679 -2,882,776	-83%	-$54.2M	0.02%	517
2024 Q3	$69.5M	Buy	3,474,455 +92,281	+3%	+$1.44M	0.14%	141
2024 Q2	$37.8M	Buy	3,382,174 +35,707	+1%	+$300K	0.09%	180
2024 Q1	$22.1M	Sell	3,346,467 -598,758	-15%	-$3.27M	0.06%	259
2023 Q4	$17.8M	Sell	3,945,225 -1,088,946	-22%	-$4.03M	0.05%	316
2023 Q3	$18M	Sell	5,034,171 -605,799	-11%	-$2.33M	0.06%	269
2023 Q2	$20.8M	Sell	5,639,970 -1,025,051	-15%	-$3.8M	0.08%	225
2023 Q1	$22.1M	Buy	6,665,021 +4,299,301	+182%	+$14.9M	0.09%	221
2022 Q4	$9.18M	Buy	2,365,720 +1,297,973	+122%	+$4M	0.04%	400
2022 Q3	$2.6M	Sell	1,067,747 -21,360	-2%	-$51.2K	0.01%	639
2022 Q2	$2.16M	Buy	1,089,107 +585,707	+116%	+$1.15M	0.01%	807
2022 Q1	$921K	Buy	503,400 +371,956	+283%	+$580K	﹤0.01%	1075
2021 Q4	$185K	Buy	131,444 +49,899	+61%	+$65.6K	﹤0.01%	1380
2021 Q3	$92K	Buy	81,545 +19,169	+31%	+$26.9K	﹤0.01%	1262
2021 Q2	$100K	Sell	62,376 -14,811	-19%	-$26.1K	﹤0.01%	1168
2021 Q1	$136K	Buy	+77,187	New	+$177K	﹤0.01%	1165
2020 Q3	–	Sell	-412,534	Closed	-$1.21M	–	1101
2020 Q2	$1.21M	Buy	+412,534	New	+$1.19M	0.01%	748